NASDAQ:TOI Oncology Institute - TOI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.66 -0.07 (-10.13%) (As of 03/28/2023 05:23 PM ET) Add Compare Share Share Today's Range$0.62▼$0.7350-Day Range$0.48▼$1.6552-Week Range$0.46▼$10.26Volume106,506 shsAverage Volume167,834 shsMarket Capitalization$49.17 millionP/E RatioN/ADividend YieldN/APrice Target$6.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Oncology Institute MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside884.8% Upside$6.50 Price TargetShort InterestBearish3.48% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 5 Articles This WeekInsider TradingAcquiring Shares$27,500 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.31 out of 5 starsMedical Sector280th out of 1,002 stocksOffices & Clinics Of Medical Doctors Industry2nd out of 7 stocks 3.5 Analyst's Opinion Consensus RatingOncology Institute has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.50, Oncology Institute has a forecasted upside of 884.8% from its current price of $0.66.Amount of Analyst CoverageOncology Institute has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.48% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in Oncology Institute has recently increased by 12.04%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOncology Institute does not currently pay a dividend.Dividend GrowthOncology Institute does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TOI. Previous Next 2.9 News and Social Media Coverage News SentimentOncology Institute has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Oncology Institute this week, compared to 2 articles on an average week.Search Interest17 people have searched for TOI on MarketBeat in the last 30 days. This is an increase of 55% compared to the previous 30 days.MarketBeat Follows1 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oncology Institute insiders have bought more of their company's stock than they have sold. Specifically, they have bought $27,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.40% of the stock of Oncology Institute is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions70.45% of the stock of Oncology Institute is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Oncology Institute is -3.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oncology Institute is -3.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOncology Institute has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Oncology Institute (NASDAQ:TOI) StockThe Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.Read More Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Email Address TOI Stock News HeadlinesMarch 23, 2023 | americanbankingnews.comGuggenheim Trims Oncology Institute (NASDAQ:TOI) Target Price to $3.00March 22, 2023 | americanbankingnews.comThe Oncology Institute, Inc. (NASDAQ:TOI) Director Richard A. Barasch Purchases 50,000 SharesMarch 28, 2023 | Porter & Company (Ad)A strange force is brewing…An economic force with the potential to be bigger than the 1880s railroad boom, the 1920s automobile boom, the baby boom of the 1960s, or the Dotcom boom of the ‘90s. And while Biden has nothing to do with it… he’ll take full credit. March 22, 2023 | americanbankingnews.comOncology Institute (NASDAQ:TOI) Price Target Cut to $3.00March 17, 2023 | finance.yahoo.comCORRECTION -- The Oncology Institute Reports Updated Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023March 11, 2023 | seekingalpha.comThe Oncology Institute, Inc. (TOI) Q4 2022 Earnings Call TranscriptMarch 11, 2023 | finance.yahoo.comIs It Time To Consider Buying The Oncology Institute, Inc. (NASDAQ:TOI)?March 11, 2023 | finance.yahoo.comThe Oncology Institute, Inc. (NASDAQ:TOI) Q4 2022 Earnings Call TranscriptMarch 28, 2023 | Porter & Company (Ad)A strange force is brewing…An economic force with the potential to be bigger than the 1880s railroad boom, the 1920s automobile boom, the baby boom of the 1960s, or the Dotcom boom of the ‘90s. And while Biden has nothing to do with it… he’ll take full credit. March 10, 2023 | finance.yahoo.comQ4 2022 Oncology Institute Inc Earnings CallMarch 9, 2023 | msn.comThe Oncology Institute reports Q4 results, provides FY 2023 revenue guidanceMarch 9, 2023 | finance.yahoo.comThe Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023March 4, 2023 | finance.yahoo.comFlorida Cancer Specialists & Research Institute a Top Performer in the Center for Medicare & Medicaid Innovation's Oncology Care ModelFebruary 18, 2023 | bizjournals.comSA lands millions in new state cancer research fundingFebruary 16, 2023 | msn.comUganda Cancer Institute Starts New Form of Treatment for Cancer, Leukemia PatientsFebruary 16, 2023 | technews.tmcnet.comLeading Oncology Patient-Reported Outcomes Technology Company Launches Commercialization of Computerized Cancer Symptom Management PathwaysFebruary 16, 2023 | finance.yahoo.comThe Oncology Institute, Inc. (TOI)February 16, 2023 | finance.yahoo.comThe Oncology Institute Announces Fourth Quarter & Full Year 2022 Earnings Release Date and Conference CallFebruary 7, 2023 | msn.comPrecision Oncology – the new way forwardFebruary 1, 2023 | forbes.comDetecting Cancer Early: How Biomarker Research Is Paving The Way ForwardJanuary 30, 2023 | finance.yahoo.comHemato-Oncology Testing Market will value USD 8.56 billion by 2030 : GreyViewsJanuary 18, 2023 | seekingalpha.comTOI The Oncology Institute, Inc.January 14, 2023 | msn.comHow this AI tool for breast cancer can tell you if you need chemotherapy or notDecember 19, 2022 | finance.yahoo.comThe Oncology Institute Expands Into Chino, CADecember 15, 2022 | benzinga.comAmerican Oncology Network Physicians Research Presented at 64th ASH Annual Meeting & ExpositionDecember 15, 2022 | finance.yahoo.comThe Oncology Institute Rebrands Clinical Trials DivisionDecember 3, 2022 | benzinga.comTampa General Hospital's Cancer Institute Awarded Coveted Accreditation from Commission on Cancer (CoC)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Email Address TOI Company Calendar Today3/28/2023Next Earnings (Estimated)5/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Offices & clinics of medical doctors Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TOI CUSIPN/A CIK1799191 Webtheoncologyinstitute.com Phone562-735-3226FaxN/AEmployees658Year FoundedN/APrice Target and Rating Average Stock Price Forecast$6.50 High Stock Price Forecast$10.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+885.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$150,000.00 Net Margins0.66% Pretax Margin-0.04% Return on Equity-29.38% Return on Assets-15.82% Debt Debt-to-Equity Ratio0.65 Current Ratio4.39 Quick Ratio4.08 Sales & Book Value Annual Sales$252.48 million Price / Sales0.19 Cash Flow$0.01 per share Price / Cash Flow44.55 Book Value$1.68 per share Price / Book0.39Miscellaneous Outstanding Shares74,550,000Free Float66,799,000Market Cap$49.17 million OptionableNot Optionable Beta1.01 Key ExecutivesMr. Richard Alan Barasch (Age 68)Exec. Chairman Mr. Bradford D. HivelyCEO & DirectorDr. Daniel Virnich FACHE (Age 43)M.B.A., M.D., MBA, Pres Comp: $297.6kMs. Hilda Agajanian M.B.A.Founder & Chief Growth OfficerDr. Richy Agajanian M.D.Founder & Chief Clinical OfficerMr. Mihir Arunkumar Shah CPA (Age 44)Chief Financial Officer Dr. Matthew Miller M.B.A. (Age 45)M.D., Chief Operating Officer Mr. Rakesh Singh M.B.A.Director of TechnologyMr. G. Philip RegerChief Information OfficerMr. Mark Hueppelsheuser Esq.Gen. CounselMore ExecutivesKey CompetitorsLifeMDNASDAQ:LFMDTScan TherapeuticsNASDAQ:TCRXClearside BiomedicalNASDAQ:CLSDMilestone ScientificNYSE:MLSSAspira Women's HealthNASDAQ:AWHView All CompetitorsInsiders & InstitutionsRichard A BaraschBought 50,000 shares on 3/17/2023Total: $27,500.00 ($0.55/share)Josh Arnold Investment Consultant LLCBought 104,400 shares on 2/16/2023Ownership: 0.140%Jefferies Financial Group Inc.Bought 192,452 shares on 2/15/2023Ownership: 0.259%Morgan StanleyBought 16,989 shares on 2/15/2023Ownership: 0.025%Two Sigma Investments LPBought 50,492 shares on 2/14/2023Ownership: 0.068%View All Insider TransactionsView All Institutional Transactions TOI Stock - Frequently Asked Questions Should I buy or sell Oncology Institute stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oncology Institute in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TOI shares. View TOI analyst ratings or view top-rated stocks. What is Oncology Institute's stock price forecast for 2023? 2 Wall Street analysts have issued 12 month price targets for Oncology Institute's shares. Their TOI share price forecasts range from $3.00 to $10.00. On average, they expect the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 885.6% from the stock's current price. View analysts price targets for TOI or view top-rated stocks among Wall Street analysts. How have TOI shares performed in 2023? Oncology Institute's stock was trading at $1.65 at the start of the year. Since then, TOI stock has decreased by 60.0% and is now trading at $0.6595. View the best growth stocks for 2023 here. When is Oncology Institute's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. View our TOI earnings forecast. What guidance has Oncology Institute issued on next quarter's earnings? Oncology Institute issued an update on its FY 2023 earnings guidance on Thursday, March, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $290.00 million-$320.00 million, compared to the consensus revenue estimate of $308.75 million. What is Oncology Institute's stock symbol? Oncology Institute trades on the NASDAQ under the ticker symbol "TOI." Who are Oncology Institute's major shareholders? Oncology Institute's stock is owned by many different institutional and retail investors. Top institutional investors include Geode Capital Management LLC (0.71%), Triatomic Management LP (0.70%), Jefferies Financial Group Inc. (0.26%), Josh Arnold Investment Consultant LLC (0.14%), Two Sigma Investments LP (0.07%) and Alpine Global Management LLC (0.06%). Insiders that own company stock include Havencrest Healthcare Partners, Matthew P Miller, Mohit Kaushal, Richard A Barasch and Richy Agajanian. View institutional ownership trends. How do I buy shares of Oncology Institute? Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Oncology Institute's stock price today? One share of TOI stock can currently be purchased for approximately $0.66. How much money does Oncology Institute make? Oncology Institute (NASDAQ:TOI) has a market capitalization of $49.17 million and generates $252.48 million in revenue each year. The company earns $150,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. How many employees does Oncology Institute have? The company employs 658 workers across the globe. How can I contact Oncology Institute? Oncology Institute's mailing address is 345 PARK AVENUE SOUTH, NEW YORK NY, 10010. The official website for the company is theoncologyinstitute.com. The company can be reached via phone at 562-735-3226 or via email at investors@theoncologyinstitute.com. This page (NASDAQ:TOI) was last updated on 3/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.